Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
ARAKODA
product3 mentionslast seen Oct 27, 2026
A tafenoquine-based product for the treatment of babesiosis.
Relationships 6
- U.S. Food and Drug AdministrationapprovesARAKODA99% confidence2 sources
- 60 Degrees Pharmaceuticals, Inc.commercializesARAKODA99% confidence2 sources
- ARAKODAapplies tomalaria prevention95% confidence1 source
- Walter Reed Army Institute of ResearchauthoredARAKODA90% confidence1 source
- ARAKODAapplies tobabesiosis treatment85% confidence1 source
- 60 Degrees Pharmaceuticals, Inc.commercializesARAKODA75% confidence1 source
Relationship
60 Degrees Pharmaceuticals, Inc.commercializesARAKODA
99% confidence2 supporting mentionsfrom Jan 1, 2019
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGAROct 27, 202660 DEGREES PHARMACEUTICALS, INC. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Tafenoquine is approved in the United States for malaria prophylaxis under the product name ARAKODA® and in Australia as KODATEF®. Both were commercially launched in 2019 and are currently distributed through pharmaceutical wholesaler networks in each respective country
- filingSEC EDGAROct 6, 202660 DEGREES PHARMACEUTICALS, INC. 8-K: Item 7.01: Regulation FD Disclosure; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
ARAKODA is sold commercially in the U.S. and Australia